Ginseng and anticancer drug combination to improve cancer chemotherapy: A critical review

Evidence-based Complementary and Alternative Medicine

Volumn 2014, Issue , 2014, Pages

  Chen, Shihong ^a,b   Wang, Zhijun ^b   Huang, Ying ^b   O'Barr, Stephen A ^b   Wong, Rebecca A ^b   Yeung, Steven ^b   Chow, Moses Sing Sum ^b  

^a Xiamen Medical College   (China)

^b WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DOCETAXEL; DOXORUBICIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL; GEMCITABINE; GINSENG EXTRACT; GINSENG POLYSACCHARIDE; GINSENOSIDE; GINSENOSIDE RD; GINSENOSIDE RG 3; HERBACEOUS AGENT; HOMOHARRINGTONINE; IRINOTECAN; MESSENGER RNA; MITOMYCIN; MULTIDRUG RESISTANCE PROTEIN; NAVELBINE; PACLITAXEL; PHOSPHATIDYLINOSITOL 3 KINASE; VASCULOTROPIN;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; CANCER COMBINATION CHEMOTHERAPY; CELL CYCLE REGULATION; CHINESE; CLINICAL STUDY; COLON CANCER; COLOR ULTRASOUND FLOWMETRY; EMBRYONAL CARCINOMA STEM CELL; EVIDENCE BASED PRACTICE; G1 PHASE CELL CYCLE CHECKPOINT; GINSENG; HERB; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LUNG NON SMALL CELL CANCER; LYMPHOCYTE PROLIFERATION; NONHUMAN; PANAX QUINQUEFOLIUS; QUALITY CONTROL; REVIEW;

EID: 84901024079     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2014/168940     Document Type: Review

References (63)

1. Che C. T., Wang Z. J., Chow M. S. S., Lam C. W. K., Herb-herb combination for therapeutic enhancement and advancement: theory, practice and future perspectives. Molecules 2013 18 5125 5141
2. Wang Z. J., Xie C., Huang Y., Lam C. W. K., Chow M. S. S., Overcoming chemotherapy resistance with herbal medicines: past, present and future perspectives. Phytochemistry Reviews 2014 13 1 323 337
3. Qi F., Li A., Inagaki Y., Gao J., Li J., Kokudo N., Li X. K., Tang W., Chinese herbal medicines as adjuvant treatment during chemo- or radio-therapy for cancer. BioScience Trends 2010 4 6 297 307
4. Vogler B. K., Pittler M. H., Ernst E., The efficacy of ginseng. A systematic review of randomised clinical trials. European Journal of Clinical Pharmacology 1999 55 8 567 575 2-s2.0-0032830802 10.1007/s002280050674 (Pubitemid 29489202)
5. Lü J., Yao Q., Chen C., Ginseng compounds: an update on their molecular mechanisms and medical applications. Current Vascular Pharmacology 2009 7 3 293 302 2-s2.0-69149110615 10.2174/157016109788340767
6. Smolinski A. T., Pestka J. J., Modulation of lipopolysaccharide-induced proinflammatory cytokine production in vitro and in vivo by the herbal constituents apigenin (chamomile), ginsenoside Rb1 (ginseng) and parthenolide (feverfew). Food and Chemical Toxicology 2003 41 10 1381 1390 2-s2.0-0141655182 10.1016/S0278-6915(03)00146-7 (Pubitemid 37289187)
7. Blumenthal M., Herb sales down 15 percent in mainstream market. HerbalGram 2001 51, article 69
8. Nag S. A., Qin J. J., Wang W., Wang M. H., Wang H., Zhang R., Ginsenosides as anticancer agents: in vitro and in vivo activities, structure-activity relationships, and molecular mechanisms of action. Frontiers in Pharmacology 2012 3 25 1 18
9. Kaufman D. W., Kelly J. P., Rosenberg L., Anderson T. E., Mitchell A. A., Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. The Journal of the American Medical Association 2002 287 3 337 344 2-s2.0-0037116642 (Pubitemid 34251967)
10. Yun T., Choi S., Preventive effect of ginseng intake against various human cancers: a case-control study on 1987 pairs. Cancer Epidemiology Biomarkers and Prevention 1995 4 4 401 408 2-s2.0-0029034101
11. Liu T., Huang Y., Cui D., Huang X., Mao S., Ji L., Song H., Yi C., Inhibitory effect of ginsenoside Rg3 combined with gemcitabine on angiogenesis and growth of lung cancer in mice. BMC Cancer 2009 9, article 250 2-s2.0-68249155377 10.1186/1471-2407-9-250
12. Hua H. Q., Shen X. K., Qin S. K., Chen H. Y., Anti-invasion and anti-metastasis effects of ginsenoside Rg3 on the hepatocellular carcinoma cell line. Zhongguo Ai Zheng Za Zhi 2005 15 4 326 330
13. Leung K. W., Cheung L. W. T., Pon Y. L., Wong R. N. S., Mak N. K., Fan T.-P. P., Au S. C. L., Tombran-Tink J., Wong A. S. T., Ginsenoside Rb1 inhibits tube-like structure formation of endothelial cells by regulating pigment epithelium-derived factor through the oestrogen β receptor. British Journal of Pharmacology 2007 152 2 207 215 2-s2.0-34948887630 10.1038/sj.bjp.0707359 (Pubitemid 47517604)
14. Papapetropoulos A., A ginseng-derived oestrogen receptor β (ER β) agonist, Rb1 ginsenoside, attenuates capillary morphogenesis. British Journal of Pharmacology 2007 152 2 172 174 2-s2.0-34948814000 10.1038/sj.bjp.0707360 (Pubitemid 47517605)
15. Fishbein A. B., Wang C., Li X., Mehendale S. R., Sun S., Aung H. H., Yuan C., Asian ginseng enhances the anti-proliferative effect of 5-fluorouracil on human colorectal cancer: comparison between white and red ginseng. Archives of Pharmacal Research 2009 32 4 505 513 2-s2.0-65549094129 10.1007/s12272-009-1405- 9
16. Gu C. X., Qiao J. P., Zhu M. L., Du J. L., Shang W. H., Yin W., Wang W., Han M., Lu W. D., Preliminary evaluation of the interactions of Panax ginseng and Salvia miltiorrhiza Bunge with 5-fluorouracil on pharmacokinetics in rats and pharmacodynamics in human cells. The American Journal of Chinese Medicine 2013 41 2 443 458
17. Chang Y. S., Seo E., Gyllenhaal C., Block K. I., Panax ginseng: a role in cancer therapy? Integrative Cancer Therapies 2003 2 1 13 33 2-s2.0-0042320415 10.1177/1534735403251167 (Pubitemid 37101984)
18. Du G., Wang C., Zhang Z., Wen X., Somogyi J., Calway T., He T., Du W., Yuan C., Caspase-mediated pro-apoptotic interaction of panaxadiol and irinotecan in human colorectal cancer cells. Journal of Pharmacy and Pharmacology 2012 64 5 727 734 2-s2.0-84859562308 10.1111/j.2042-7158.2012.01463.x
19. Li X., Wang C., Mehendale S. R., Sun S., Wang Q., Yuan C., Panaxadiol, a purified ginseng component, enhances the anti-cancer effects of 5-fluorouracil in human colorectal cancer cells. Cancer Chemotherapy and Pharmacology 2009 64 6 1097 1104 2-s2.0-69049106403 10.1007/s00280-009-0966-0
20. Matsunaga H., Katano M., Saita T., Yamamoto H., Mori M., Potentiation of cytotoxicity of mitomycin C by a polyacetylenic alcohol, panaxytriol. Cancer Chemotherapy and Pharmacology 1994 33 4 291 297 2-s2.0-0028175024 10.1007/s002800050055
21. Kim S. M., Lee S. Y., Yuk D. Y., Moon D. C., Choi S. S., Kim Y., Han S. B., Oh K., Hong J. T., Inhibition of NF- B by ginsenoside Rg3 enhances the susceptibility of colon cancer cells to docetaxel. Archives of Pharmacal Research 2009 32 5 755 765 2-s2.0-67649361895 10.1007/s12272-009-1515-4
22. Kim S. M., Lee S. Y., Cho J. S., Son S. M., Choi S. S., Yun Y. P., Yoo H. S., Yoon D. Y., Oh K., Han S. B., Hong J. T., Combination of ginsenoside Rg3 with docetaxel enhances the susceptibility of prostate cancer cells via inhibition of NF- B. European Journal of Pharmacology 2010 631 1-3 1 9 2-s2.0-76549121864 10.1016/j.ejphar.2009.12.018
23. Gao R., Jin J., Niu Y., Potentiated effects of total saponins of Panax ginseng on inhibition of leukemic cells by cytotoxic drugs. Zhongguo Zhong Xi Yi Jie He Za Zhi 1999 19 1 17 19 2-s2.0-0032889077
24. Baek S. H., Piao X. L., Lee U. J., Kim H. Y., Park J. H., Reduction of cisplatin-induced nephrotoxicity by ginsenosides isolated from processed ginseng in cultured renal tubular cells. Biological and Pharmaceutical Bulletin 2006 29 10 2051 2055 2-s2.0-33749451019 10.1248/bpb.29.2051 (Pubitemid 44510808)
25. Yokozawa T., Dong E., Role of ginsenoside-Rd in cisplatin-induced renal injury: special reference to DNA fragmentation. Nephron 2001 89 4 433 438 2-s2.0-0035200385 10.1159/000046116 (Pubitemid 33135824)
26. Choi C., Kang G., Min Y., Reversal of P-glycoprotein-mediated multidrug resistance by protopanaxatriol ginsenosides from Korean red ginseng. Planta Medica 2003 69 3 235 240 2-s2.0-0037363620 10.1055/s-2003-38483 (Pubitemid 36470128)
27. Shin M. J., Kim Y. S., Kwak Y. S., Song Y. B., Kim Y. S., Park J. D., Enhancement of antitumor effects of paclitaxel (taxol) in combination with red ginseng acidic polysaccharide (RGAP). Planta Medica 2004 70 11 1033 1038 2-s2.0-9744225102 10.1055/s-2004-832643 (Pubitemid 39587036)
28. Miao M., Liu Q., Liu Y. R., Chemo-sensitivity enhancing effects of Shengai injection on various chemotherapeutic drugs. Chinese Traditional and Herbal Drugs 2013 44 7 875 876
29. Raghavendran H. R. B., Rekha S., Shin J., Kim H., Wang J., Park H., Choi M., Cho J., Son C., Effects of Korean ginseng root extract on cisplatin-induced emesis in a rat-pica model. Food and Chemical Toxicology 2011 49 1 215 221 2-s2.0-78650280733 10.1016/j.fct.2010.10.019
30. Kim J., Yoon I., Lee B., Choi S., Lee J., Lee J., Sang M. J., Kim S., Park C., Lee S., Nah S., Effects of Korean red ginseng extract on cisplatin-induced nausea and vomiting. Archives of Pharmacal Research 2005 28 6 680 684 2-s2.0-24944562026 10.1007/BF02969358 (Pubitemid 43073634)
31. Du X. F., Jiang C. Z., Wu C. F., Won E. K., Choung S. Y., Synergistic immunostimulating activity of pidotimod and red ginseng acidic polysaccharide against cyclophosphamide-induced immunosuppression. Archives of Pharmacal Research 2008 31 9 1153 1159 2-s2.0-52649136542 10.1007/s12272-001-1282-6
32. Shim J. Y., Han Y., Ahn J. Y., Yun Y. S., Song J., Chemoprotective and adjuvant effects of immunomodulator ginsan in cyclophosphamide-treated normal and tumor bearing mice. International Journal of Immunopathology and Pharmacology 2007 20 3 487 497 2-s2.0-34948850764 (Pubitemid 47531052)
33. Ni W., Zhang X., Wang B., Chen Y., Han H., Fan Y., Zhou Y., Tai G., Antitumor activities and immunomodulatory effects of ginseng neutral polysaccharides in combination with 5-fluorouracil. Journal of Medicinal Food 2010 13 2 270 277 2-s2.0-77958193646
34. Xu T., Xin Y., Cui M., Jiang X., Gu L., Inhibitory effect of ginsenoside Rg3 combined with cyclophosphamide on growth and angiogenesis ovarian cancer. Chinese Medical Journal 2007 120 7 584 588 2-s2.0-34247365969 (Pubitemid 46629914)
35. Ernst E., Panax ginseng: an overview of the clinical evidence. Journal of Ginseng Research 2010 34 4 259 263 2-s2.0-79951777625 10.5142/jgr.2010.34.4.259
36. Zhang Q., Kang X., Zhao W., Antiangiogenic effect of low-dose cyclophosphamide combined with ginsenoside Rg3 on Lewis lung carcinoma. Biochemical and Biophysical Research Communications 2006 342 3 824 828 2-s2.0-33644618424 10.1016/j.bbrc.2006.02.044 (Pubitemid 43320472)
37. Kenarova B., Neychev H., Hadjiivanova C., Petkov V. D., Immunomodulating activity of ginsenoside Rg1 from Panax ginseng. Japanese Journal of Pharmacology 1990 54 4 447 454 2-s2.0-0025681804
38. Chen Z., Wang P., Huang W., Liu L., Experimental study on effects of shengmai injection: enhancing 5-FU anti-tumor efficacy and reducing its toxicity. Journal of Chinese Integrative Medicine 2005 3 6 476 479 2-s2.0-33746665300
39. Ge M., Fang Y. Y., Liu G. P., Guan S. D., Effect of Shengmai injection on diaphragmatic contractility in doxorubicin-treated rats. Chinese Journal of Integrative Medicine 2014 20 1 43 48
40. Chen Y., Li Z., Gao F., Zhang Y., Sun H., Li P., Effects of combined Chinese drugs and chemotherapy in treating advanced non-small cell lung cancer. Chinese Journal of Integrative Medicine 2009 15 6 415 419 2-s2.0-73849130756 10.1007/s11655-009-0415-2
41. Yan A. Y., Guo S. J., Yi Y. J., Effect of Shengmai injection "Sandwich" infusion to prevent patients with chemotherapy induced phlebitis. Chinese Nursing Research 2004 18 20 1859 1860
42. Zhao Z., Liao Z. J., Zhao X. H., The clinic research of the effect of SHENG MAI injection combined with the chemotherapy in the elderly patients with advanced gastric cancer. Journal of Mordern Oncology 2005 13 3 387 388
43. Lo L. C., Chen C. Y., Chen S. T., Chen H. C., Lee T. C., Chang C. S., Therapeutic efficacy of traditional Chinese medicine, Shen-Mai San, in cancer patients undergoing chemotherapy or radiotherapy: study protocol for randomized, double-blind, placebo-controlled trial. Trials 2012 13, article 232
44. Liu J. W., Sun L. X., Zhao Y., Clinical phase II study on immunoimprovement of patients with breast cancer treated by Shengyi capsule. Chinese Journal of Clinical Oncology 2000 27 7 534 544
45. Sun Y., Zhu H., Zhu Y., Feng J., Chen Z., Li G., Zhang X., Zhang Z., Tang J., Shi M., Hao X., Han H., A randomized, prospective, multi-centre clinical trial of NP regimen (vinorelbine+cisplatin) plus Gensing Rg3 in the treatment of advanced non-small cell lung cancer patients. Chinese Journal of Lung Cancer 2006 9 3 254 258 2-s2.0-33745736315 (Pubitemid 44013527)
46. Huang J., Sun Y., Fan Q., Zhang Y., Efficacy of Shenyi Capsule combined with gemcitabine plus cisplatin in treatment of advanced esophageal cancer: a randomized controlled trial. Journal of Chinese Integrative Medicine 2009 7 11 1047 1051 2-s2.0-73949087913 10.3736/jcim20091105
47. Coon J. T., Ernst E., Panax ginseng: a systematic review of adverse effects and drug interactions. Drug Safety 2002 25 5 323 344 2-s2.0-0036283370 (Pubitemid 34634271)
48. Qi L., Wang C., Du G., Zhang Z., Calway T., Yuan C., Metabolism of ginseng and its interactions with drugs. Current Drug Metabolism 2011 12 9 818 822 2-s2.0-80053535953
49. Popovich D. G., Yeo C. R., Zhang W., Ginsenosides derived from Asian (Panax ginseng), American ginseng (Panax quinquefolius) and potential cytoactivity. International Journal of Biomedical and Pharmaceutical Sciences 2012 6 1 56 62
50. Yun T. K., Brief introduction of Panax ginseng C.A. Meyer. Journal of Korean Medical Science 2001 16 supplement S3 S5 2-s2.0-0035650950
51. Yun T., Panax ginseng-a non-organ-specific cancer preventive? The Lancet Oncology 2001 2 1 49 55 2-s2.0-0035240033 10.1016/S1470-2045(00)00196-0 (Pubitemid 33585917)
52. Shin H. R., Kim J. Y., Yun T. K., Morgan G., Vainio H., The cancer-preventive potential of Panax ginseng: a review of human and experimental evidence. Cancer Causes and Control 2000 11 6 565 576 2-s2.0-0034075605 10.1023/A:1008980200583 (Pubitemid 30342846)
53. Kang S., Min H., Ginseng, the "immunity boost": the effects of Panax ginseng on immune system. Journal of Ginseng Research 2012 36 4 354 368
54. Lim S., Cho C., Choi U., Kim Y., Antioxidant activity and ginsenoside pattern of fermented white ginseng. Journal of Ginseng Research 2010 34 3 168 174 2-s2.0-79951791059 10.5142/jgr.2010.34.3.168
55. Harkey M. R., Henderson G. L., Gershwin M. E., Stern J. S., Hackman R. M., Variability in commercial ginseng products: an analysis of 25 preparations. American Journal of Clinical Nutrition 2001 73 6 1101 1106 2-s2.0-0034982633 (Pubitemid 32496951)
56. Mizuno M., Yamada J., Terai H., Kozukue N., Lee Y. S., Tsuchida H., Differences in immunomodulating effects between wild and cultured Panax ginseng. Biochemical and Biophysical Research Communications 1994 200 3 1672 1678 2-s2.0-0028260549 10.1006/bbrc.1994.1644 (Pubitemid 24181845)
57. Zhang X., Yu L., Bi H., Li X., Ni W., Han H., Li N., Wang B., Zhou Y., Tai G., Total fractionation and characterization of the water-soluble polysaccharides isolated from Panax ginseng C. A. Meyer. Carbohydrate Polymers 2009 77 3 544 552 2-s2.0-67349202467 10.1016/j.carbpol.2009.01.034
58. Gao X. G., Zhi Y., Sun L., Peng X. X., Zhang T., Xue H. T., Tai G. H., Zhou Y. F., The inhibitory effects of a rhamnogalacturonan I, (RG-I) domain from ginseng pectin on galectin-3 and its structure-activity relationship. The Journal of Biological Chemistry 2013 288 47 33953 33965
59. Chu Y., Zhang H. C., Li S. M., Wang J. M., Wang X. Y., Li W., Zhang L. L., Ma X. H., Zhou S. P., Zhu Y. H., Liu C. X., Determination of ginsenoside Rc in rat plasma by LC-MS/MS and its application to a pharmacokinetic study. Journal of Chromatography B: analytical Technologies in the Biomedical and Life Sciences 2013 919-920 75 78
60. Lv C., Li Q., Zhang Y., Sui Z., He B., Xu H., Yin Y., Chen X., Bi K., A UFLC-MS/MS method with a switching ionization mode for simultaneous quantitation of polygalaxanthone III, four ginsenosides and tumulosic acid in rat plasma: application to a comparative pharmacokinetic study in normal and Alzheimer's disease rats. Journal of Mass Spectrometry 2013 48 8 904 913
61. Sparreboom A., Cox M. C., Acharya M. R., Figg W. D., Herbal remedies in the United States: potential adverse interactions with anticancer agents. Journal of Clinical Oncology 2004 22 12 2489 2503 2-s2.0-2942729844 10.1200/JCO.2004.08.182 (Pubitemid 41115408)
62. Wang B. X., Cui J. C., Liu A. J., The action of ginsenosides extracted from the stems and leaves of Panax ginseng in promoting animal growth. Acta Pharmaceutica Sinica 1982 17 12 899 904 2-s2.0-0020407407
63. Helms S., Cancer prevention and therapeutics: Panax ginseng. Alternative Medicine Review 2004 9 3 259 274 2-s2.0-4644356962 (Pubitemid 39299200)